Summary
The clearest overlap between Semax and Thymosin Alpha-1 is that both converge around Signaling modulator. Their typical research and application settings separate fairly clearly: Semax is more often discussed in the realm of Neurology and brain health and Ophthalmology, whereas Thymosin Alpha-1 is more often associated with the realm of Immunology and inflammation and Oncology. Both appear to work through Signaling modulator, but the functional emphasis still separates, with Semax leaning toward Neuroprotection and cognition and Thymosin Alpha-1 leaning toward Immune regulation and Anti-inflammatory. Semax has a more synthetic analog origin, while Thymosin Alpha-1 is closer to natural endogenous background and their development context also differs, with Semax approved for Research use only while Thymosin Alpha-1 is approved. Thymosin Alpha-1 incorporates acetylation features that are not part of Semax.